Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)
Clinical trial NCT02005757 · UNKNOWN
Trial details
- NCT number
- NCT02005757
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2016-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.